57 related articles for article (PubMed ID: 12466640)
21. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
22. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
Shasha D; George MJ; Harrison LB
Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.
Harrison LB; Shasha D; Homel P
Oncology; 2002; 63 Suppl 2():11-8. PubMed ID: 12466640
[TBL] [Abstract][Full Text] [Related]
25. The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy.
Dunst J
Semin Oncol; 2001 Apr; 28(2 Suppl 8):42-8. PubMed ID: 11395852
[TBL] [Abstract][Full Text] [Related]
26. [Epoetin alfa in radiotherapy].
Trodella L; Balducci M; Gambacorta MA; Mantini G
Tumori; 1998; 84(6 Suppl 1):S15-9. PubMed ID: 10083890
[TBL] [Abstract][Full Text] [Related]
27. Raising hemoglobin: an opportunity for increasing survival?
Thomas GM
Oncology; 2002; 63 Suppl 2():19-28. PubMed ID: 12466641
[TBL] [Abstract][Full Text] [Related]
28. The negative impact of anemia on radiotherapy and chemoradiation outcomes.
Shasha D
Semin Hematol; 2001 Jul; 38(3 Suppl 7):8-15. PubMed ID: 11523023
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
31. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
32. External radiotherapy and anaemia treatment: state of the art.
Ozsahin M; Azria D; Beer K; Mirimanoff RO; Zouhair A
Swiss Med Wkly; 2005 Jan; 135(1-2):4-10. PubMed ID: 15662573
[TBL] [Abstract][Full Text] [Related]
33. rHuEPO and treatment outcomes: the clinical experience.
Hudis CA; Van Belle S; Chang J; Muenstedt K
Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
[TBL] [Abstract][Full Text] [Related]
34. Administration of Epoetin alfa. Case study of the anemic patient.
Cutler M
ANNA J; 1997 Aug; 24(4):459-65; quiz 466. PubMed ID: 9325701
[TBL] [Abstract][Full Text] [Related]
35. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
36. Epoetin alfa use in gynecology. Past, present and future.
Bachmann GA
J Reprod Med; 2001 May; 46(5 Suppl):539-44. PubMed ID: 11396388
[TBL] [Abstract][Full Text] [Related]
37. Anemia treatment and the radiation oncologist: optimizing patient outcomes.
Shasha D; Harrison LB
Oncology (Williston Park); 2001 Nov; 15(11):1486-91; discussion 1494-6. PubMed ID: 11758875
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
